StonvexLoading…
StonvexStonvexStonvexCore line items from ROK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.34B | $2.10B | $8.34B | $6.03B |
Operating Income | $965.00M | $435.00M | $1.70B | $854.00M |
Net Income | $655.00M | $305.00M | $869.00M | $731.00M |
EPS (Diluted) | $5.79 | $2.69 | $7.67 | $6.43 |
Total Assets | $11.26B | $11.23B | $11.22B | $11.19B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $423.00M | $444.00M | $468.00M | $495.00M |
Free Cash Flow OCF − CapEx | $445.00M | $170.00M | $1.36B | $953.00M |
Shares Outstanding | 112.70M | 112.90M | 112.40M | 113.20M |